A Study of MOMA-341 Alone or in Combination With Irinotecan or Pembrolizumab in People With Solid Tumor Cancer

Full Title

A Phase 1 Study of MOMA-341 as Monotherapy or Combination Therapy in Participants with Advanced or Metastatic Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Michael Foote’s office at 646-888-5261.

Protocol
26-243
Phase
Phase I (phase 1)
Investigator
Michael Foote
Co-Investigators
Andrea Cercek
Diseases
Colorectal Cancer
Endometrial and other Uterine Cancers › Endometrial Cancer
Solid Tumors
Upper Gastrointestinal
Upper Gastrointestinal › Esophageal Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06974110
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description